PriTest is establishing a new industry standard for detection of TB infection.

PriTest intends to become the market leader in TB and other microbial testing by providing solutions based on innovative and proprietary technology.

PriTest has developed breakthrough diagnostic tests for tuberculosis infection: TBfree™ for Mycobacterium tuberculosis testing in people, and SeraLyte-Mbv™ for Mycobacterium bovis testing of livestock. Our easy-to-use pathogen detection system offers a combination of speed and sensitivity not found on the market today.

We are proving our technology through validation work for SeraLyte-Mbv with three national government agricultural departments, including the United States Department of Agriculture. To advance TBfree™human testing validation, we have established collaborations with key foundations, organizations and industry leaders. Additional validation information for TBfree™is available upon request.

PriTest’s principals jointly have more than 50 years of experience in biomedical product development, regulatory approval, commercialization, and successful entrepreneurship. We have worked hard to create innovative testing products that can make a positive difference in fighting the world’s most devastating diseases.